ACC

Associates of Cape Cod, Inc. (ACC) is a global leader in the specialized field of endotoxin and (1→3)-ß-D-glucan detection. Founded in 1974, the company was the first to receive an FDA license for the manufacture of Limulus Amebocyte Lysate (LAL) reagents, which are essential for testing the safety of injectable pharmaceuticals, biologics, and medical devices. ACC provides a comprehensive suite of products, including gel-clot, turbidimetric, and chromogenic LAL assays, as well as the Fungitell® diagnostic for invasive fungal infections. As a subsidiary of Seikagaku Corporation, ACC operates state-of-the-art manufacturing and contract testing facilities in the United States and the United Kingdom, supporting the global healthcare industry's quality control and regulatory compliance needs.